Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-02-05 | 2023-12-22 |
| Drug Identification Number | 02491087 | 02491087 |
| Brand name | EMGALITY | EMGALITY |
| Common or Proper name | galcanezumab injection | galcanezumab injection |
| Company Name | ELI LILLY CANADA INC | ELI LILLY CANADA INC |
| Ingredients | GALCANEZUMAB | GALCANEZUMAB |
| Strength(s) | 120MG | 120MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | Carton package containing one 120 mg/mL single-use prefilled pen | Carton package containing one 120 mg/mL single-use prefilled pen |
| ATC code | N02CD | N02CD |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-12-22 | 2023-12-22 |
| Actual start date | 2023-12-22 | 2023-12-22 |
| Estimated end date | 2024-02-08 | 2024-02-08 |
| Actual end date | 2024-02-02 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Shortage due to global manufacturing constraints and allocation. The estimated end date represents projected availability at the main Lilly warehouse. For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). | Shortage due to global manufacturing constraints and allocation. The estimated end date represents projected availability at the main Lilly warehouse. For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments |